by [email protected] | Nov 27, 2023 | Gastrointestinal, immunology, Publication
ABSTRACT Background: There is limited real-world evidence on treatment patterns of patients with Crohn’s disease (CD) initiating biologics with an extensive follow-up period. This study describes persistence and dose titration among CD patients with 3 years of...
by [email protected] | Feb 14, 2023 | immunology, Publication
Abstract Objective: Assess healthcare costs associated with systemic lupus erythematosus (SLE) flares among patients with and without lupus nephritis (LN). Methods: This retrospective cohort study used medical and pharmacy claims data from the United...
by [email protected] | Apr 28, 2022 | Gastrointestinal, immunology, Publication
Abstract Objective: This real-world study evaluated biologic treatment patterns in moderate-to-severe ulcerative colitis (UC) patients. Methods: IQVIA® PharMetrics®, IBM® MarketScan®, and Optum Clinformatics™ were pooled to identify UC patients with ≥1 claim for UC...
by [email protected] | Apr 4, 2022 | immunology, Publication
Abstract Aims: Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease involving multiple organs systems and places a significant economic burden on SLE patients. There is a literature gap regarding the standard of care and economic burden in...
by [email protected] | Dec 15, 2021 | Gastrointestinal, immunology, Publication
Abstract Amanda Teeple, Janvi Sah, Rajesh Mallampati, Christopher Adams, Dexter Waters, Erik Muser Background This study examined biologic persistence, dosing, and other treatment patterns among Crohn’s disease (CD) patients that initiated adalimumab (ADA),...
by [email protected] | Nov 4, 2021 | Gastrointestinal, immunology, Publication
Authors: Grace Chen, Vasantha Pedarla, Kyle D Null, Susan E Cazzetta, Qasim Rana Khan, David A Schwartz Abstract Background: Perianal fistula (PAF), a complication of Crohn’s disease (CD), is associated with substantial economic costs and poor prognosis. We...
